Related Experiment Video

Updated: Jun 4, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Optimizing preclinical study design in oncology research

Luke A Wittenburg1, Daniel L Gustafson

  • 1Flint Animal Cancer Center, Department of Clinical Sciences, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523-1620, United States. Luke.Wittenburg@colostate.edu

Chemico-Biological Interactions
|February 8, 2011
PubMed

Insights

Improving oncology drug development requires better preclinical studies. An integrated pharmacokinetic/pharmacodynamic approach can enhance efficacy and toxicity prediction, reducing clinical trial failures for new cancer therapeutics.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Development

Background:

  • High attrition rates in oncology drug development are linked to inadequate preclinical studies.
  • Current preclinical models may not accurately predict efficacy or toxicity for novel targeted cancer agents.
  • There is a critical need for improved preclinical evaluation methods in cancer research.

Purpose of the Study:

  • To highlight the limitations of current preclinical studies in oncology drug development.
  • To propose an integrated pharmacokinetic/pharmacodynamic (PK/PD) approach to improve preclinical evaluation.
  • To reduce the failure rate of new cancer drugs in clinical trials.

Main Methods:

  • Discussing the limitations of conventional preclinical endpoints for cytostatic agents.
  • Advocating for the integration of pharmacokinetic and pharmacodynamic analyses.
  • Emphasizing the importance of selecting appropriate preclinical model systems.

Main Results:

  • Current preclinical methods often fail to predict clinical outcomes accurately.
  • PK/PD modeling offers a more comprehensive understanding of drug behavior.
  • Appropriate model selection is crucial for reliable preclinical data.

Conclusions:

  • An integrated PK/PD approach, coupled with suitable models, can significantly improve oncology drug development.
  • This strategy enhances the understanding of efficacy and toxicity determinants.
  • Ultimately, this leads to a reduction in drug attrition during clinical trials.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...